Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,076 public trials 1,849 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Breath Analysis to Diagnose Lung Cancer

NCT03250390

Conditions
Disease, Lung Cancer, Lung Diseases, +8 more
Locations
  • Institut Pasteur - Centre de Prévention et d'Education à la Santé (CPES) Lille, France
  • Hôpital Calmette, CHU Lille, France
  • Hopital Victor Provo Roubaix, France
  • Centre Hospitalier de Saint Quentin Saint-Quentin, France
View Trial Details
Completed

An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)

NCT01853826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • The Prince of Wales Hospital Randwick, New South Wales, Australia
  • Sunshine Hospital AT Albans, Victoria, Australia
  • St John of God Murdoch Murdoch, Western Australia, Australia
  • Medical University of Graz State Hospital - University Hospital Graz Graz, Austria
View all 118 locations
View Trial Details
Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details
Completed

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

NCT04943900

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +21 more
Locations
  • Local Institution - 0006 Atlanta, Georgia, United States
  • Local Institution - 0005 Baltimore, Maryland, United States
  • Local Institution - 0002 Hackensack, New Jersey, United States
  • Local Institution - 0013 Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03631706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncology Specialties, PC; Clearview Cancer Institute Huntsville, Alabama, United States
  • Cedars Sinai Medical Center - Inflammatory Bowel Disease Center (Clinic Los Angeles, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Kaiser Permanente - Harbor City San Diego, California, United States
View all 119 locations
View Trial Details

Related conditions